Prices delayed by at least 15 minutes | Print
Legal & General Ucits Etf Public Limited Company L&G HEALTHCARE TECH & INNOVATION USD ACC (DOCG)
Open
1,401.60p
Previous close
1,391.00p
Trade high
1,407.20p
Income frequency
-
Year low
927.20p
Year high
1,407.60p
Replication method
Physical Full
Volume
12,966
Type
ETF
UCITS
Yes
Dividend yield
–
Ongoing charge
0.49
ISIN
IE00BK5BC677
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Regular investment and Dividend reinvestment
Before investing please read:
Share price
Asset allocation
Top 10 holdings
| Holdings 25/09/2026 | % of assets |
|---|---|
| Twist Bioscience Corp | 2.83 |
| GRAIL Inc | 2.56 |
| Tempus AI Inc Class A common stock | 2.44 |
| Natera Inc | 2.43 |
| Illumina Inc | 2.20 |
| Intuitive Surgical Inc | 2.13 |
| Thermo Fisher Scientific Inc | 2.12 |
| Guardant Health Inc | 2.12 |
| Adaptive Biotechnologies Corp | 2.06 |
| Moderna Inc | 1.98 |
Investment objective
The investment objective of the Fund is to provide exposure to the global healthcare technology industry. In order to achieve this investment objective, the Fund will seek to track the performance of the ROBO Global® Healthcare Technology and Innovation Index TR (the “Index”). It will do so by investing primarily in a portfolio of equity securities that, as far as possible and practicable, consists of the component securities of the Index in similar proportions to their weightings in the Index and may have exposure to or invest directly up to 20% of its Net Asset Value in shares issued by the same body, which limit may be raised to 35% for a single issuer in exceptional market conditions, including (but not limited to) circumstances in which such issuer occupies a dominant market position.
This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.